Results 101 to 110 of about 1,245,456 (166)

Voie de signalisation Notch3 dans les artères cérébrales

, 2012
Le gène Notch3 code pour un récepteur transmembranaire hétérodimérique exprimé principalement dans les cellules musculaires lisses des petites artères.
JOUTEL, Anne, FOUILLADE, Charles
core  

NOTCH3 Internal Tandem Duplication Defines a Novel Oncogenic Activation Mechanism of NOTCH Signaling. [PDF]

Genes Chromosomes Cancer
Gao H, Chen S, Wu Y, Fu J, Mao R, Yang M, Li Y, Bao Z, Chen H, Feng J, Meng L, Xiao S.   +11 more
europepmc   +1 more source

Impairment of hippocampal gamma oscillations, mitochondria and neurovascular function in CADASIL. [PDF]

Brain
Shao W, Oliveira DV, Naia L, Li Y, Bjørnholm KD, Isla AG, Uhlén P, Kalaria R, Lesnik Oberstein SAJ, Lendahl U, Enrique Arroyo-García L, Jin S, Karlström H.   +12 more
europepmc   +1 more source

Targeting the Notch Signaling Pathway to Treat Atherosclerosis. [PDF]

Cells
Blagov A, Borodko D, Rozhkova U, Antonov S, Utkina A, Kovyanova T.   +5 more
europepmc   +1 more source

NOTCH3 disrupts the osteoblast transcriptome in femoral bone of 1-month-old male C57BL/6 mice. [PDF]

Bone
Canalis E, Schilling L, Denker E.
europepmc   +1 more source

Small molecule-mediated activation of Notch signal transduction. [PDF]

Cell Death Dis
Dey S, Giaimo BD, Zöllner IK, Yang Q, Zarrin H, Ballout J, Diener M, Friedrich T, Ferrante F, Dreute J, Schmitz ML, Weiss A, Polo P, Lauth M, Gahr B, Just S, Bartkuhn M, Oswald F, Borggrefe T.   +18 more
europepmc   +1 more source

LncRNA <i>RAMS11</i>-dependent <i>NOTCH3</i> activation drives tumor progression in non-small cell lung cancer. [PDF]

NAR Cancer
Jeffers GG, Kim Y, White NM, Lin L, Rozycki EB, Ly A, Maher CA.   +6 more
europepmc   +1 more source

Notch3/4 Knockdown Inhibits Colon Adenocarcinoma Progression by Suppressing Tumor Cell Activity and Orchestrating VEGFA-Dependent Tumor Immune Microenvironment. [PDF]

Cancer Med
Liu W, Tang G, Li N, Wang J, Zhao H, Li C.   +5 more
europepmc   +1 more source

Camrelizumab plus nimotuzumab as second-line therapy for advanced esophageal squamous cell carcinoma: a multicenter phase II study. [PDF]

J Immunother Cancer
Xia J, Meng X, Jiang G, Hong Y, Ji Y, Wang C, Yang X, Meng Y, Zhang W, Luo Z, Cui D, Wang J, Shan Z, Guan L, Lu Y, Yang X, Ren C, Meng X, Wang H, Shen L, Zhang Y, Kou Z, Lu T, Fan Q, Quante M, Zhao T, Li S, Wang F.   +27 more
europepmc   +1 more source

NOTCH3 regulates myofibroblastic CAF differentiation via the P62-ROS signaling axis to promote bladder cancer progression. [PDF]

J Exp Clin Cancer Res
Hu D, Shen C, Liu C, Xie F, Wang X, Wang H, Chen Y, Zhao X, Qin R, Li C, Ge H, Zhu J, Xi Z, Wang Y.   +13 more
europepmc   +1 more source